Plasma Microbial Cell-Free DNA Metagenomic Sequencing Bridges Gaps in the Diagnosis, Epidemiology and Surveillance of Legionella Infections
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
ABSTRACT Conventional diagnostic methods (CDM) for Legionella preferentially detect L. pneumophila and frequently fail to identify non-pneumophila species (NPLS), obscuring the full clinical spectrum of infection and limiting surveillance accuracy. We analyzed plasma microbial cell-free DNA (mcfDNA) sequencing detections of Legionella spp. from a large clinical cohort tested between 2018 and 2024 and compared species distributions with culture and PCR confirmed cases reported in the most recent national surveillance datasets (2018-2021). To contextualize the clinical impact, we reviewed published reports in which mcfDNA sequencing was used to diagnose legionellosis (2021–2025) and evaluated real-world performance data from a hospital contributing 8.9% of detections within the cohort (Hospital A). mcfDNA sequencing identified proportionally fewer L. pneumophila , more NPLS, and fewer unresolved species than the CDC reports (all p
Fields of Study & Subjects
Legionella and Acanthamoeba research
Bacterial Identification and Susceptibility Testing
Infections and bacterial resistance
Publication details
- Journal / source
- medRxiv
- Publication date
- 26 March 2026
- Language
- EN
- Document type
- Preprint